Sg Americas Securities, LLC Veracyte, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 20,309 shares of VCYT stock, worth $886,690. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,309

Previous 8,703 133.36%

Holding current value

$886,690

Previous $189,000 265.61%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$21.0 - $35.25 $243,726 - $409,111	11,606 Added 133.36%	20,309 $691,000
Q2 2024 Jul 12, 2024	BUY	$18.86 - $23.55 $44,641 - $55,742	2,367 Added 37.36%	8,703 $189,000
Q1 2024 May 06, 2024	BUY	$21.0 - $29.1 $133,056 - $184,377	6,336 New	6,336 $140,000
Q3 2023 Oct 13, 2023	BUY	$22.33 - $29.92 $389,837 - $522,343	17,458 New	17,458 $390,000
Q1 2023 Apr 28, 2023	BUY	$20.58 - $27.89 $73,841 - $100,069	3,588 Added 29.87%	15,600 $348,000
Q4 2022 Feb 02, 2023	BUY	$15.31 - $29.94 $30,926 - $60,478	2,020 Added 20.22%	12,012 $285,000
Q3 2022 Oct 31, 2022	SELL	$16.58 - $27.9 $858,628 - $1.44 Million	-51,787 Reduced 83.83%	9,992 $166,000
Q2 2022 Jul 29, 2022	BUY	$15.45 - $29.52 $796,957 - $1.52 Million	51,583 Added 505.91%	61,779 $1.23 Million
Q1 2022 Apr 29, 2022	SELL	$21.94 - $42.51 $199,588 - $386,713	-9,097 Reduced 47.15%	10,196 $281,000
Q4 2021 Feb 07, 2022	SELL	$36.09 - $53.79 $15,554 - $23,183	-431 Reduced 2.19%	19,293 $795,000
Q3 2021 Nov 01, 2021	BUY	$35.62 - $52.97 $77,010 - $114,521	2,162 Added 12.31%	19,724 $916,000
Q2 2021 Aug 12, 2021	SELL	$32.94 - $56.62 $134,131 - $230,556	-4,072 Reduced 18.82%	17,562 $702,000
Q1 2021 May 13, 2021	BUY	$44.47 - $81.38 $860,494 - $1.57 Million	19,350 Added 847.2%	21,634 $1.16 Million
Q4 2020 Feb 04, 2021	SELL	$32.49 - $61.88 $667,474 - $1.27 Million	-20,544 Reduced 89.99%	2,284 $112,000
Q3 2020 Nov 09, 2020	BUY	$26.73 - $35.67 $484,213 - $646,162	18,115 Added 384.36%	22,828 $742,000
Q2 2020 Jul 20, 2020	SELL	$19.49 - $28.11 $123,001 - $177,402	-6,311 Reduced 57.25%	4,713 $122,000
Q1 2020 Apr 30, 2020	SELL	$16.13 - $30.17 $29,840 - $55,814	-1,850 Reduced 14.37%	11,024 $268,000
Q4 2019 Jan 28, 2020	BUY	$20.78 - $29.99 $267,521 - $386,091	12,874 New	12,874 $359,000
Q3 2019 Nov 04, 2019	SELL	$23.87 - $30.93 $153,221 - $198,539	-6,419 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$22.1 - $28.56 $141,859 - $183,326	6,419 New	6,419 $183,000
Q1 2019 Apr 29, 2019	SELL	$12.0 - $25.76 $1.97 Million - $4.22 Million	-163,780 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$9.15 - $14.85 $1.38 Million - $2.23 Million	150,440 Added 1127.74%	163,780 $2.06 Million
Q3 2018 Nov 06, 2018	BUY	$9.55 - $12.64 $127,397 - $168,617	13,340 New	13,340 $127,000
Q2 2018 Aug 07, 2018	SELL	$5.39 - $9.66 $79,071 - $141,712	-14,670 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$5.44 - $6.97 $19,339 - $24,778	3,555 Added 31.98%	14,670 $82,000
Q4 2017 Jan 24, 2018	BUY	$6.05 - $9.37 $67,245 - $104,147	11,115	11,115 $73,000

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.13B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Veracyte, Inc. Transaction History